Emotional distress and future healthcare utilization in oncology populations: A systematic review
- PMID: 38483339
- DOI: 10.1002/pon.6322
Emotional distress and future healthcare utilization in oncology populations: A systematic review
Abstract
Objective: Emotional distress has been correlated with greater healthcare utilization and economic costs in cancer; however, the prospective relationship between positive distress screens and future healthcare utilization is less clear. Taken together, there is a critical need to synthesize studies examining the prospective relationship between emotional distress and future healthcare use to inform distress management protocols and motivate institutional resource allocation to distress management. The aim of the systematic review is to explore the relationship between emotional distress, measured via validated emotional distress questionnaires, and subsequent healthcare utilization in patients diagnosed with cancer.
Methods: A systematic search of seven databases was conducted on 29 March 2022 and updated 3 August 2023. Eligibility criteria were: (1) peer-reviewed, (2) quantitative or mixed methods, (3) adults (≥18 years) diagnosed with cancer, (4) cancer distress questionnaire(s) completed prior to healthcare utilization, and (5) written in English. Exclusion criteria included: (1) non-emotional aspects of distress (i.e., spiritual or physical distress), (2) healthcare utilization characterized via economic or monetary variables, and (3) caregiver or non-cancer populations.
Results: Nineteen peer-reviewed articles were included in the review. There was significant heterogeneity in emotional distress instruments and type of healthcare utilization used. Most studies examining general distress or anxiety found that increased distress was predictive of greater future healthcare utilization.
Conclusion: The results suggest that individuals with higher levels of general distress and anxiety are at increased risk for future healthcare utilization.
Keywords: anxiety; cancer distress; depression; healthcare utilization; psycho-oncology; screening.
© 2024 John Wiley & Sons Ltd.
References
REFERENCES
-
- Riba MB, Donovan KA, Ahmed K, et al. NCCN Guidelines® insights: distress management, version 2.2023: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2023;21(5):450-457. https://doi.org/10.6004/jnccn.2023.0026
-
- Riba MB, Donovan KA, Andersen B, et al. Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw J Natl Compr Canc Netw. 2019;17(10):1229-1249. https://doi.org/10.6004/jnccn.2019.0048
-
- Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605-1619. https://doi.org/10.1200/jco.2013.52.4611
-
- Pirl W, Nekhlyudov L, Rowland JH, Lacchetti C, Andersen BL. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update Q&A. JCO Oncol Pract. 2023;19(9):714-717. https://doi.org/10.1200/op.23.00324
-
- Andersen BL, Lacchetti C, Ashing K, et al. Management of anxiety and depression in adult survivors of cancer: ASCO guideline update. J Clin Oncol. 2023;41(18):3426-3453. https://doi.org/10.1200/jco.23.00293
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical